Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 2Phase 1 1

Status

Recruiting 2Active not recruiting 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Myeloid 6Other hematologic neoplasm 1

Conditions

Breast Neoplasms 3099Neoplasms 2443Carcinoma, Non-Small-Cell Lung 1867Prostatic Neoplasms 1619Colorectal Neoplasms 1426Lung Neoplasms 1295Multiple Myeloma 929Neoplasm Metastasis 920Leukemia, Myeloid, Acute 874Pancreatic Neoplasms 848Ovarian Neoplasms 799Melanoma 784Carcinoma, Hepatocellular 737Stomach Neoplasms 639Brain Neoplasms 636Recurrence 633Squamous Cell Carcinoma of Head and Neck 632Head and Neck Neoplasms 609Glioblastoma 567Lymphoma 540Uterine Cervical Neoplasms 539Triple Negative Breast Neoplasms 505Precursor Cell Lymphoblastic Leukemia-Lymphoma 499Carcinoma, Renal Cell 499Hematologic Neoplasms 463Urinary Bladder Neoplasms 459Endometrial Neoplasms 459Colonic Neoplasms 442Lymphoma, Non-Hodgkin 436Sarcoma 434

Interventions

imetelstat 1Spectroscopy, Near-Infrared 1GRN163L peptide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Polycythemia × 1 year × Clear all
NCT07527221 2026-06-01

Safety and Tolerability of ZE74-0282 in Healthy Volunteers

Eilean Therapeutics

Phase 1 Recruiting
40 enrolled
MyeloidOther hematologic neoplasm

Polycythemia, Thrombocythemia, Essential, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Primary Myelofibrosis

NCT07341048 2026-01-15

ACTIVAQ

Hospices Civils de Lyon

Phase NA Not yet recruiting
54 enrolled
Myeloid

Polycythemia, Polycythemia Vera

NCT04576156 2025-12-04

A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment

Geron Corporation

Phase 3 Active not recruiting
327 enrolled
Myeloid

Myeloproliferative Disorders, Polycythemia, Thrombocytosis, Primary Myelofibrosis

NCT06421025 2025-11-21

POLYVISCO

Hospices Civils de Lyon

Recruiting
160 enrolled
Myeloid

Polycythemia, Polycythemia Vera, Thrombosis

NCT03008642 2025-09-19

Poly-CO

Centre Hospitalier Universitaire, Amiens

Phase NA Completed
60 enrolled
Myeloid

Myeloproliferative Disorders, Polycythemia

NCT05481151 2025-08-13

A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV

PharmaEssentia

Phase 3 Active not recruiting
111 enrolled
Myeloid

Polycythemia, Polycythemia Vera, Thrombocythemia, Essential

Data powered by HemOnc (CC BY 4.0) Colophon âš¡